EXTRUSION OF EARTHWORM CELOMOCYTES - COMPARISON OF THE CELL-POPULATIONS RECOVERED FROM THE SPECIES LUMBRICUS-TERRESTRIS, EISENIA-FETIDA ANDOCTOLASION-TYRTAEUM
J. Diogene et al., EXTRUSION OF EARTHWORM CELOMOCYTES - COMPARISON OF THE CELL-POPULATIONS RECOVERED FROM THE SPECIES LUMBRICUS-TERRESTRIS, EISENIA-FETIDA ANDOCTOLASION-TYRTAEUM, Laboratory animals, 31(4), 1997, pp. 326-336
Coelomocytes were extruded from three earthworm species: Lumbricus ter
restris, Eisenia fetida and Octolasion tyrtaeum. Featuring a simple lo
w-vacuum holding device, the proposed methodology allows the recovery
of cells with;minimum risk of contamination by faecal material. The vi
ability of O. tyrtaeum coelomocytes was highly reproducible (average 9
3%), with an average yield of 0.92 x 10(6) viable cells per earthworm.
Cell. viability for L. terrestris and E. fetida averaged similar to 6
8% but the cell yields were higher (respectively 1.67 x 10(6) and 1.28
x 10(6)). Large inter-individual differences in cell yields were obse
rved with L, terrestris. Flow cytometric analyses indicated species to
species differences in cell populations. Coelomocytes from E, fetida
were the smallest with similar to 57% of the total, viable cells recov
ered being monitored between 2 and 10 mu m. Large granulated cells (gr
eater than or equal to 20 mu m) were detected in fairly large proporti
ons in L, terrestris and O, tyrtaeum (similar to 52 and similar to 96%
, respectively) while they were less abundant in E, fetida (similar to
9%). Using the vital dye neutral red to assess functional integrity,
average cellular uptakes were significantly higher for L, terrestris a
nd O, tyrtaeum than for E, fetida (2.94, 2.66 and 0.64 mu g/2 x 10(5)
cells, respectively). In summary, the extrusion methodology herein des
cribed is applicable for the recovery of coelomocytes from a wide rang
e of earthworm sizes and species. Moreover, this study strengthens the
fact that extruded coelomocytes could be used for the evaluation of c
ell dysfunction and/or cell death following an in vitro and/or in vivo
treatment.